Support James Plouffe's ALS Stem Cell Therapy

Adam Plouffe and Kayla Palmer are raising funds for James Plouffe. James was diagnosed with ALS (Lou Gehrig’s disease) in April 2022 and at that time they gave him 6 months to 2 years to live. (Thankfully he is past that point). The first symptoms were slurred speech two years prior to a diagnosis.

This condition has significantly affected his ability to speak and swallow, though thankfully, it hasn’t impacted his limbs. (We don’t understand this because in most cases it does).

James has faced numerous obstacles, including issues with insurance, doctors, and specialty pharmacies. Despite extensive testing and procedures in hopes of finding an alternative diagnosis, everything continues to point to ALS.

He does have one more study that is scheduled for September 16th with another neurosurgeon because back in 2020 when the slurred speech occurred, James had just had neck surgery from a car accident he was in.

Recently, we received hopeful news. Some of James’s friends discovered that stem cell therapy has shown promise for ALS patients. Thanks to their efforts, James’s son, Adam, has worked tirelessly to get him into this program, and today we learned that James has been approved. While this offers hope, the treatments are costly—and need to start urgently.

Any support, whether through a donation, sharing this post, or offering kind words of encouragement, is deeply appreciated.

Thank you all for your support during his journey.